Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Recruiting

Phase 1

FT536Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Sponsor:

Masonic Cancer Center, University of Minnesota

Code:

NCT06342986

Conditions

Gynecologic Cancer

Ovarian Cancer

Fallopian Tube Cancer

Primary Peritoneal Cavity Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FT536

Fludarabine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-10. This information was provided to ClinicalTrials.gov by Masonic Cancer Center, University of Minnesota on 2025-11-12.